Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2020), Nature Medicine
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2020), Nature Medicine
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
Journal article
Rollier CS. et al, (2020), Scientific Reports, 10
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2020), The Lancet
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Journal article
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells.
Journal article
Bowyer G. et al, (2020), The Journal of experimental medicine, 217
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Journal article
Folegatti PM. et al, (2020), The Lancet. Infectious diseases, 20, 816 - 826
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Journal article
Gilchrist JJ. et al, (2020), BMC medicine, 18
The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.
Journal article
Auckland K. et al, (2020), Scientific reports, 10
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial
Journal article
Cappuccini F. et al, (2020), Journal for ImmunoTherapy of Cancer, 8, e000928 - e000928
Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice.
Journal article
Bliss CM. et al, (2020), Molecular therapy. Methods & clinical development, 16, 108 - 125
Estimating the burden of iron deficiency among African children.
Journal article
Muriuki JM. et al, (2020), BMC medicine, 18
Elevated risk of invasive group A streptococcal disease and host genetic variation in the human leucocyte antigen locus
Journal article
Parks T. et al, (2020), Genes & Immunity, 21, 63 - 70
Vaccine innovations for emerging infectious diseases-a symposium report.
Journal article
Cable J. et al, (2020), Annals of the New York Academy of Sciences, 1462, 14 - 26
Identification of antigens presented by MHC for vaccines against tuberculosis.
Journal article
Bettencourt P. et al, (2020), NPJ Vaccines, 5
Generation of Novel Plasmodium falciparum NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive Promoters.
Journal article
Miyazaki S. et al, (2020), Frontiers in Cellular and Infection Microbiology, 10
The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection.
Journal article
Du Y. et al, (2020), Frontiers in Immunology, 11
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
Journal article
Stedman A. et al, (2019), npj Vaccines, 4
Use of gene expression studies to investigate the human immunological response to malaria infection
Journal article
Hodgson SH. et al, (2019), Malaria Journal, 18